Angiotensin converting enzyme inhibitors in congestive heart failure: Overview in comparison of captopril and enalapril

Keyphrases

• Congestive Heart Failure 100%
• Enalapril 100%
• Captopril 100%
• Angiotensin-converting Enzyme Inhibitor (ACEi) 100%
• Chemical Structure 40%
• Long-term Efficacy 20%
• Vasodilator 20%
• Efficacy Trial 20%
• Renin-angiotensin System 20%
• Adverse Effects 20%
• Peak Effect 20%
• Action Effects 20%
• Right Ventricular 20%
• Physiological Function 20%
• Plasma Renin Activity 20%
• Enzyme Inhibition 20%
• Diuretics 20%
• Hemodynamic Assessment 20%
• Left Ventricular Function 20%
• Prostaglandin Production 20%
• Aldosterone 20%
• Dose-response Curve 20%
• Pharmacological Activities 20%
• Converting Enzyme 20%
• Digitalis 20%
• Drug Regimen 20%
• Aortic Impedance 20%
• Ventricular Filling Pressure 20%
• Symptomatic Improvement 20%
• Hormonal Changes 20%
• Onset of Action 20%
• Long Duration of Action 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Captopril 100%
• Dipeptidyl Carboxypeptidase Inhibitor 100%
• Congestive Heart Failure 100%
• Enalapril 100%
• Renin 40%
• Enzyme Inhibition 20%
• Vasodilator Agent 20%
• Dipeptidyl Carboxypeptidase 20%
• Adverse Event 20%
• Diuretic Agent 20%
• Aldosterone 20%
• Angiotensin 20%
• Prostaglandin 20%